These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2153208)

  • 1. Highly selective kappa-opioid analgesics. 3. Synthesis and structure-activity relationships of novel N-[2-(1-pyrrolidinyl)-4- or -5-substituted-cyclohexyl]arylacetamide derivatives.
    Halfpenny PR; Horwell DC; Hughes J; Hunter JC; Rees DC
    J Med Chem; 1990 Jan; 33(1):286-91. PubMed ID: 2153208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly selective kappa opioid analgesics. 4. Synthesis of some conformationally restricted naphthalene derivatives with high receptor affinity and selectivity.
    Halfpenny PR; Horwell DC; Hughes J; Humblet C; Hunter JC; Neuhaus D; Rees DC
    J Med Chem; 1991 Jan; 34(1):190-4. PubMed ID: 1846919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly selective kappa-opioid analgesics. 2. Synthesis and structure-activity relationships of novel N-[(2-aminocyclohexyl)aryl]acetamide derivatives.
    Halfpenny PR; Hill RG; Horwell DC; Hughes J; Hunter JC; Johnson S; Rees DC
    J Med Chem; 1989 Jul; 32(7):1620-6. PubMed ID: 2567782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
    de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC
    J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly selective kappa opioid analgesics. Synthesis and structure-activity relationships of novel N-[(2-aminocyclohexyl)aryl]acetamide and N-[(2-aminocyclohexyl)aryloxy]acetamide derivatives.
    Clark CR; Halfpenny PR; Hill RG; Horwell DC; Hughes J; Jarvis TC; Rees DC; Schofield D
    J Med Chem; 1988 Apr; 31(4):831-6. PubMed ID: 2832603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of (1',2'-trans)-3-phenyl-1-[2'-(N-pyrrolidinyl)cyclohexyl]pyrrolid -2-ones as kappa-selective opiates.
    Cheng CY; Lu HY; Lee FM; Tam SW
    J Pharm Sci; 1990 Aug; 79(8):758-62. PubMed ID: 2172511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective reversible and irreversible ligands for the kappa opioid receptor.
    Cheng CY; Wu SC; Hsin LW; Tam SW
    J Med Chem; 1992 Jun; 35(12):2243-7. PubMed ID: 1319495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of N-substituted cis-N-methyl-2-(1-pyrrolidinyl)cyclohexylamines as high affinity sigma receptor ligands. Identification of a new class of highly potent and selective sigma receptor probes.
    de Costa BR; Rice KC; Bowen WD; Thurkauf A; Rothman RB; Band L; Jacobson AE; Radesca L; Contreras PC; Gray NM
    J Med Chem; 1990 Nov; 33(11):3100-10. PubMed ID: 2172538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kappa agonists PD117302 and U50488 produce a biphasic effect on 24 hour food intake in the rat.
    Hewson G; Hill RG; Hughes J; Leighton GE; Turner WD
    Neuropharmacology; 1987 Nov; 26(11):1581-4. PubMed ID: 2829048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse.
    Horan PJ; de Costa BR; Rice K; Haaseth RC; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 1993 Aug; 266(2):926-33. PubMed ID: 8394923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kappa opioid receptor agonists suppress absence seizures in WAG/Rij rats.
    Przewłocka B; Lasoń W; Machelska H; van Luijtelaar G; Coenen A; Przewłocki R
    Neurosci Lett; 1995 Feb; 186(2-3):131-4. PubMed ID: 7777181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in the stereochemistry of the kappa-selective opioid agonist U50,488 result in high-affinity sigma ligands.
    de Costa BR; Bowen WD; Hellewell SB; George C; Rothman RB; Reid AA; Walker JM; Jacobson AE; Rice KC
    J Med Chem; 1989 Aug; 32(8):1996-2002. PubMed ID: 2547074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
    Vonvoigtlander PF; Lahti RA; Ludens JH
    J Pharmacol Exp Ther; 1983 Jan; 224(1):7-12. PubMed ID: 6129321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-(3,4-Dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-1-substituted- ethyl]-acetamides: the use of conformational analysis in the development of a novel series of potent opioid kappa agonists.
    Costello GF; James R; Shaw JS; Slater AM; Stutchbury NC
    J Med Chem; 1991 Jan; 34(1):181-9. PubMed ID: 1846918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pertussis and cholera toxins modulate kappa-opioid receptor agonists-induced hypothermia and gut inhibition.
    Shukla VK; Turndorf H; Bansinath M
    Eur J Pharmacol; 1995 Mar; 292(3-4):293-9. PubMed ID: 7796869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supraspinal administration of opioids with selectivity for mu-, delta- and kappa-opioid receptors produces analgesia in amphibians.
    Stevens CW; Rothe KS
    Eur J Pharmacol; 1997 Jul; 331(1):15-21. PubMed ID: 9274924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats.
    Yamamoto T; Ohno M; Ueki S
    Eur J Pharmacol; 1988 Oct; 156(1):173-6. PubMed ID: 2850208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of kappa opioids in rhesus monkeys: behavioral effects and receptor binding affinities.
    France CP; Medzihradsky F; Woods JH
    J Pharmacol Exp Ther; 1994 Jan; 268(1):47-58. PubMed ID: 8301589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylated analogues of methyl (R)-4-(3,4-dichlorophenylacetyl)- 3-(pyrrolidin-1-ylmethyl)piperazine-1-carboxylate (GR-89,696) as highly potent kappa-receptor agonists: stereoselective synthesis, opioid-receptor affinity, receptor selectivity, and functional studies.
    Soukara S; Maier CA; Predoiu U; Ehret A; Jackisch R; Wünsch B
    J Med Chem; 2001 Aug; 44(17):2814-26. PubMed ID: 11495592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.